•
Sep 30, 2024

Allovir Q3 2024 Earnings Report

Total Revenue
$0
0
EPS
-$0.04
Previous year: -$0.39
-89.7%
Gross Profit
$0
0
Cash and Equivalents
$122M
Previous year: $213M
-42.9%
Free Cash Flow
-$8.44M
Total Assets
$123M
Previous year: $248M
-50.7%

Allovir

Allovir